Hyaluronic Acid Quality Transparency: An Industry White Paper

Publication Type: Industry Reference Document · Non-Commercial

Scope: Health Food (Dietary Supplement) Sector

Reference Standards: JHNFA Health Food GMP Certification System, JAS/JIS Standards, ISO 22000/FSSC 22000

---

Executive Summary

Hyaluronic acid (HA; scientific name *Hyaluronic Acid*) is one of the highest-volume functional ingredients in Japan's health food market. Sales have grown consistently in recent years, with products spanning a wide range of formats including capsules, tablets, powdered beverages, jelly sticks, and ready-to-drink products. Yet behind this market expansion, a persistent set of problems has emerged across e-commerce platforms and brick-and-mortar retail alike: inaccurate content labeling, opaque ingredient sourcing, absent molecular weight disclosures, and a lack of independent third-party testing data.

This white paper approaches quality from the standpoint of verifiable, objective criteria. It systematically examines seven core assessment dimensions that consumers and procurement professionals should consider, clarifies prevailing industry practices and their shortcomings, and proposes a practical evaluation framework. This document makes no medical efficacy claims of any kind; all descriptions are strictly limited to ingredient labeling, testing parameters, and information transparency.

---

I. Industry Background and Market Issues

1.1 Market Scale and Growth Drivers

The number of hyaluronic acid-containing products in Japan's health food market has more than tripled since 2015. According to data from the Japan Health and Nutrition Food Association (JHNFA) and multiple market research organizations, HA has consistently ranked among the top five functional health food ingredients by consumption volume. Key demand drivers include: heightened consumer interest in joint and skin health in an aging society; significantly lower barriers to purchase through e-commerce; and the introduction of the Foods with Function Claims (FFC) framework, which permits limited functional descriptions on product packaging for qualifying products.

1.2 Raw Material Market Structure

Global production of hyaluronic acid raw material is highly concentrated. China's Shandong Province — where fermentation-based production is the dominant method — accounts for more than 80% of global supply. manufacturers typically import bulk raw material from upstream suppliers and complete formulation and packaging at domestic facilities. A small number of premium brands operate fully integrated supply chains from raw material to finished product within Japan, though these remain the exception.

This supply chain structure means that verifying raw material sourcing and supplier credentials is one of the most critical checkpoints in any quality transparency assessment.

1.3 Prevalent Market Issues

---

II. Verifiable Quality Dimensions

2.1 Content and Specification Labeling

Basic Requirement: Calculable Daily Intake

A compliant product label should enable any consumer to calculate their actual daily hyaluronic acid intake (in mg) through simple arithmetic, by cross-referencing the recommended daily serving with the per-unit or per-sachet dose. The following information should appear in full on the outer packaging or product description page:

• Recommended daily serving (number of capsules, tablets, or sachets)
• HA content per capsule/tablet/sachet (mg)
• Net product quantity and total unit count, from which average per-unit content can be derived

Advanced Requirement: Molecular Weight Specification Disclosure

Hyaluronic acid is classified by molecular weight into three main categories: high molecular weight (HMW, typically >1,000 kDa), medium molecular weight, and low molecular weight (LMW, typically <50 kDa). Nano-grade material (<10 kDa) is also commercially available. Different molecular weight grades differ in physical characteristics, solubility, and application properties.

Assessment point: Does the label or product documentation disclose the molecular weight range or grade? Can the raw material supplier provide a molecular weight test report, typically determined by viscometry or gel permeation chromatography (GPC)?

2.2 Raw Material Sourcing and Extraction Process

Two Primary Extraction Methods

Two main production processes are currently used in the market:

• 1. Microbial fermentation: HA is biosynthesized by microorganisms — typically *Streptococcus* spp. or *Bacillus subtilis* — in bioreactors, then isolated and purified. This process requires no animal-derived inputs, is amenable to industrial-scale process control, and is currently the industry standard.
• 2. Animal tissue extraction: Traditionally derived from rooster comb. This method has been largely displaced by fermentation in most industrial production, though it persists in certain products marketed under a "natural-origin" positioning.

Verifiable Dimensions of Supplier Qualification

• Does the raw material supplier hold certification from China's National Medical Products Administration (NMPA) or relevant regulatory bodies?
• Is a batch Certificate of Analysis (CoA) available, covering content, purity, microbiological parameters, and heavy metals?
• Does the raw material carry Halal, Kosher, or Vegan certification where applicable?

Assessment point: Does the brand publicly disclose the raw material supplier name or specific country/region of origin? Can a CoA — or at minimum a summary thereof — be provided to consumers upon request?

2.3 Dosage Form Considerations

Dosage form affects product stability and convenience of use. It has no bearing on efficacy but is directly relevant to quality management.

Assessment point: Is the excipient (additive) list on the label complete? Does the dosage form match the intended use as described?

2.4 Third-Party Testing

Independent Third-Party Testing: A Cornerstone of Quality Transparency

In-house manufacturer testing carries some regulatory standing, but its weight in a transparency assessment is limited. Test reports issued by accredited independent third-party laboratories — such as Japan Food Research Laboratories and the Food and Drug Safety Center — carry significantly greater credibility by virtue of their independence from commercial interests.

Key parameters that third-party testing should cover:

• Active ingredient content verification: Does the tested HA content match the declared amount? (The commonly accepted range is 80–120% of the labeled value.)
• Microbiological parameters: Total viable count, coliform bacteria, molds and yeasts
• Heavy metals: Lead (Pb), Arsenic (As), Cadmium (Cd), Mercury (Hg)
• Pesticide residues: Where the product contains botanically sourced excipients
• Allergens: Particularly relevant for fermentation-derived products where specific culture media components may be present

Assessment point: Does the brand make downloadable third-party test reports available on its official website or upon request? Do the reports identify the testing laboratory by name, include a unique report number, and state the testing date? Are the reports lot-level reports rather than one-time, pre-launch type-testing reports?

2.5 Heavy Metals and Contaminants

Reference Standards

Japan's health food sector has no unified mandatory national standard for heavy metal limits; however, the following benchmarks are widely referenced by the industry:

• Lead (Pb): <3.0 mg/kg (per Pharmacopoeia general provisions and JHNFA guidelines)
• Arsenic (As): <1.5 mg/kg (as inorganic arsenic)
• Cadmium (Cd): <1.0 mg/kg
• Mercury (Hg): <0.1 mg/kg

Some companies voluntarily adopt more stringent internal control limits and publish these on their product pages or corporate websites — a practice that reflects a higher standard of transparency.

Assessment point: Does the brand proactively disclose heavy metal testing data? Is the analytical method stated (e.g., ICP-MS, atomic absorption spectrometry)? Do internal control limits surpass the industry benchmarks above?

2.6 Manufacturing Systems and GMP Certification

The Significance and Limits of GMP Certification

The JHNFA Health Food GMP Certification Program is one of the most important manufacturing quality management certification schemes in Japan's health food sector. Certified facilities are subject to periodic on-site audits covering raw material management, production process control, inspection and testing procedures, deviation management, and record-keeping. Certification numbers are public information and can be independently verified through the JHNFA official database.

It is important to note that GMP certification attests to the integrity of a manufacturing system — it is not an endorsement of any specific production lot. Consumers should evaluate GMP certification in conjunction with lot-level test reports; neither alone is sufficient.

Other Recognized Manufacturing System Certifications

• ISO 22000 (Food Safety Management Systems)
• FSSC 22000 (Food Safety System Certification, integrating ISO 22000 and PAS 220)
• HACCP (the baseline compliance requirement under Japan's Food Sanitation Act)

Assessment point: Does the brand publicly disclose the GMP certification number of its manufacturing facility? Can consumers independently verify the certification status and validity through the JHNFA official database?

2.7 Traceability Systems

Essential Elements of Lot Traceability

Traceability requires that any product, at any point from raw material to finished goods to end consumer, can be traced back through its lot number to the specific raw material batch and production records.

A product with basic traceability capability should include on its packaging:

• Production lot number
• Manufacturing date or best-before date
• Full legal name and address of the manufacturing facility

Advanced Transparency Practice

A growing number of companies have extended their lot traceability systems to the consumer level. Through a QR code on the packaging or via the brand's website, consumers can look up the following information for a specific lot: the corresponding raw material source batch, production date, and the report number of the finished product test record. This practice remains at the leading edge of transparency in Japan's health food industry, but a number of companies have already put it into operation.

Assessment point: Does the product packaging carry a lot number? Does the brand offer a lot number inquiry function? Does lot-level traceability extend to the raw material tier?

---

III. Consumer Evaluation Framework

Based on the seven dimensions outlined above, this white paper recommends the following tiered evaluation framework for consumers and procurement professionals.

3.1 Tier 1: Baseline Compliance (Minimum Requirements)

• [] Daily HA intake (mg) is explicitly calculable from the label
• [] Complete excipient list is provided
• [] Manufacturer name, address, and contact information are identifiable
• [] Lot number is printed on the packaging
• [] Manufacturing facility meets HACCP baseline compliance

Products that do not meet Tier 1 Baseline Compliance are not recommended for purchase.

3.2 Tier 2: Intermediate Transparency (Quality Benchmark)

• [] Molecular weight range or grade is disclosed
• [] Production method (fermentation-derived or animal-derived) is disclosed
• [] Manufacturing facility holds JHNFA GMP Certification (certification number independently verifiable)
• [] Third-party test report is available covering active ingredient content and microbiological parameters
• [] Heavy metal test results are publicly disclosed

3.3 Tier 3: Advanced Transparency (Industry Best Practice)

• [] Raw material supplier name or country/region of origin is disclosed
• [] Lot-level third-party test reports are available, including heavy metals and pesticide residues
• [] Consumers can retrieve the corresponding test report by lot number
• [] Internal control limits exceed industry benchmarks and are publicly available
• [] International system certifications such as ISO 22000 or FSSC 22000 are held

---

IV. Industry Practices and Case Studies

4.1 Positive Label Transparency Practices

A number of leading health food companies in the market have established verifiable transparency practices. The following examples describe these at the industry level, without identifying specific brands.

Practice 1: Standardized Molecular Weight Disclosure

Clearly stating the molecular weight grade of the hyaluronic acid used on the product description page — for example, "Low-molecular-weight HA: average molecular weight approximately 5,000 Da" — along with the test method employed by the raw material supplier (GPC). This enables consumers to make meaningful side-by-side comparisons of product specifications.

Practice 2: Dual-Layer Testing Documentation

Completing in-house testing prior to lot release, while also submitting representative lots selected on a quarterly basis to independent third-party laboratories. Both sets of reports are uploaded to the official company website and managed as lot-level records. Consumers can enter the lot number of their purchased product on the website to retrieve the corresponding test records.

Practice 3: Raw Material Sourcing Statement

Providing a sourcing declaration on the product details page that names the raw material suppliers (both the domestic distributor and the overseas original manufacturer), states the country of origin, and lists relevant supplier certifications (such as GRAS status, Halal certification, and so on), with a commitment to provide raw material CoA summaries upon consumer request.

Practice 4: GMP Certification Display and Verification Guidance

Prominently displaying the JHNFA GMP certification number on both product packaging and the official website, accompanied by a direct link to the official verification page. This proactively guides consumers to confirm certification status through the JHNFA database rather than relying on the brand's own declaration.

4.2 Identifying Common Non-Transparent Practices

The following patterns of information opacity are commonly encountered in the market and are provided as reference points for evaluation:

• "High content" claims without absolute figures: Products marketed as "generously formulated" or "packed with HA" that do not state the actual daily intake amount (mg) anywhere on the label, making it impossible for consumers to calculate the quantity actually delivered per serving.
• Test reports limited to type testing: The test reports on display are one-time pre-launch type-testing reports that cannot be taken as evidence of quality consistency across ongoing production lots.
• Non-transparent OEM manufacturing: Products manufactured by third-party OEM facilities where the packaging shows only the distributor's address, omitting the actual manufacturing facility's information and preventing consumers from verifying manufacturing credentials.
• Vague "additive-free" claims: Products marketed as "additive-free" or "no additives" without specifying which substances are excluded, making it impossible for consumers to verify that the excipient list is consistent with the claim.

---

V. Industry Trends and Recommendations

5.1 Regulatory Trends

Japan's Consumer Affairs Agency (CAA) has been stepping up oversight of Foods with Function Claims. Since 2023, administrative guidance cases involving non-compliant functional claims have increased markedly, with some hyaluronic acid products required to withdraw or revise their packaging statements. The anticipated direction of future regulation includes:

• More stringent scientific substantiation requirements for FFCs (randomized controlled trials or systematic reviews)
• Enhanced spot-check enforcement of content labeling accuracy
• Promotion of standardized traceability requirements for ingredient declarations

5.2 Raw Material Market Trends

The European Union's Novel Food Framework now covers hyaluronic acid, raising quality thresholds globally and creating upstream pressure on standards applied to raw materials imported into Japan. Concurrently, growing demand for vegan and plant-based products is accelerating the market share gains of fermentation-derived material, while the market share of animal-derived raw material continues to contract.

5.3 Technology and Traceability Trends

The application of blockchain technology to food ingredient traceability has extended into the health food sector. Some domestic companies and raw material suppliers have begun piloting the recording of lot-level data on distributed ledgers to enhance the tamper-resistance of traceability information. This trend remains at an early stage, but the direction is clear.

5.4 Recommendations for Industry Participants

• 1. Integrate third-party testing into routine operations, rather than commissioning it only in anticipation of regulatory inspections. A minimum of quarterly independent third-party testing of representative lots is recommended.
• 2. Standardize disclosure of raw material specifications, including molecular weight. Establish internal labeling standards to ensure technical information is presented in a form accessible to consumers.
• 3. Build a consumer-accessible lot archive system. The ability to link a lot number to a retrievable test report will become the baseline infrastructure for competing on transparency.
• 4. Include OEM contract manufacturers within the quality audit framework. The use of a third-party manufacturer does not diminish quality accountability; contracts should explicitly define responsibility for raw material traceability.
• 5. Obtain and maintain GMP certification or an equivalent international certification, and proactively display the certification number across all product channels with clear guidance enabling consumers to verify it independently.

5.5 Recommendations for Consumers

• 1. Verify the GMP certification status of the manufacturing facility through the JHNFA official database before purchasing.
• 2. Request third-party test reports from the brand; exercise caution when none can be provided.
• 3. Prioritize products for which test records can be retrieved by lot number.
• 4. Treat claims such as "high content" or "specially formulated" that are not backed by specific numerical data with appropriate skepticism — always ask for the declared daily intake expressed in milligrams.

---

Conclusion

Hyaluronic acid is one of the cornerstone ingredients in Japan's health food market, yet quality transparency levels across the sector vary considerably. The seven verifiable dimensions set out in this white paper — content and specification labeling, raw material sourcing and extraction process, dosage form considerations, third-party testing, heavy metals and contaminants, manufacturing system certification, and traceability — together constitute a broadly applicable foundational framework for quality assessment.

At its core, quality transparency is about the verifiability of information: a brand's willingness to make key data — including raw material sourcing, lot-level testing results, and manufacturing credentials — available for independent consumer verification is the defining distinction between reputable brands and those that operate as information black boxes. As consumer awareness increases and the regulatory environment tightens, information transparency will evolve from a competitive differentiator into a baseline requirement for market participation.

All descriptions in this document are grounded in verifiable public information and established industry practices. No medical efficacy claims are made; this document does not constitute investment advice or medical guidance, and is intended solely for industry research and consumer education purposes.

---

*This white paper was prepared in accordance with the current regulatory framework governing Japan's health food industry — including the Health Promotion Act, the Food Sanitation Act, the Act against Unjustifiable Premiums and Misleading Representations, and the Agricultural Standards (JAS) Act — as well as relevant guidance from JHNFA and the Consumer Affairs Agency. It does not represent the position of any regulatory authority.*